Search results for 51

Anti-Astrin/Deepest antibody [EPR28134-51], Abcam, AB323503

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

Anti-GPCR GPR52 antibody [EPR24344-51], Abcam, AB315438

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

Integrin beta 3 antibody [Y2/51], Genetex, GTX34801

Anti-Thiophosphate ester antibody [51-8], Abcam, AB133473

What is this antibody validated in? Anti-Thiophosphate ester antibody [51-8] (ab133473) is a rabbit recombinant monoclonal antibody and is validated for use in Immunoprecipitation (IP). Trusted by the scientific community Anti-Thiophosphate ester [51-8] (ab133473) was first used in a scientific publication in 2012 and has been cited over 10 times in peer-reviewed journals. Other related products We have a range of other formats of antibody clone [51-8] also available for your convenience: ab92570 , ab133473, Carrier free - ab239919 Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

Anti-Thiophosphate ester antibody [51-8], Abcam, AB92570

This antibody was developed as part of a collaboration between Abcam and the lab of Dr. Kevan Shokat at University of California at San Francisco. It is possible to use ab92570 with ab138911 as a kinase reaction reagent for the identification of direct kinase substrates as mentioned in Allen JJ et al. Nat Methods 4:511-6 (2007). After the kinase of interest has accepted ATP-γ-S ( ab138911 ), p -Nitrobenzyl mesylate ( ab138910 ) can be used to alkylate the thiophospholyation site on the substrates. ab92570 is introduced to identify the tagged substrates. Product Specifications Anti-Thiophosphate ester antibody [51-8] (ab92570) was developed by Abcam using patented rabbit monoclonal antibody technology and is validated for use in WB. Quality and Validation Abcam's high quality manufacturing and validation processes ensure Anti-Thiophosphate ester antibody [51-8] (ab92570) has high sensitivity and specificity alongside high lot-to-lot consistency and reproducibility. Anti-Thiophosphate ester antibody [51-8] (ab92570) has been cited over 86 times in peer reviewed journals and is trusted by the scientific community. Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

Anti-Allergin 1 antibody [EPR27238-51], Abcam, AB310327

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

Anti-IL-17A antibody [EPR26410-51], Abcam, AB302922

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

Anti-KDM4B / JMJD2B antibody [EPR25240-51], Abcam, AB305058

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

Anti-SHMT2/SHMT antibody [EPR28607-51], Abcam, AB316328

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

Anti-ATF2 (Phospho-Thr69 or 51) Antibody, Covalab, Ref 00123792